(Q44529239)
Statements
1 reference
Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II trial with clinical outcomes, analysis of serum tumor markers as predictive factors, and cardiac surveillance algorithm (English)
1 reference
Harold J Burstein
1 reference
Eric P Winer
1 reference
Rosemary Lambert-Falls
1 reference
Craig A Bunnell
1 reference
Lyndsay N Harris
1 reference
P Kelly Marcom
1 reference
Kathleen Havlin
1 reference
Beth Overmoyer
1 reference
Robert J Friedlander
1 reference
Janet Gargiulo
1 reference
Rochelle Strenger
1 reference
Charles L Vogel
1 reference
Paula D Ryan
1 reference
Mathew J Ellis
1 reference
Raquel A Nunes
1 reference
Susana M Campos
1 reference
Michele Hallor
1 reference
Rebecca Gelman
1 reference
1 August 2003
1 reference
1 reference
Identifiers
1 reference